Advanced search
Start date

Effects of inhibition of carbonic anhydrases 9 and 12 by E7070 in vitro and in vivo: Implications on progression and therapeutics of glioblastomas

Grant number: 11/05957-6
Support type:Scholarships in Brazil - Post-Doctorate
Effective date (Start): January 01, 2012
Effective date (End): December 31, 2015
Field of knowledge:Health Sciences - Medicine - Maternal and Child Health
Principal researcher:Carlos Alberto Scrideli
Grantee:Silvia Aparecida Teixeira
Home Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
Associated scholarship(s):14/08899-5 - Effect of the silencing of CA12 and of the activation of NF-kB pathway TNFa in glioblastoma stem cell, BE.EP.PD


Glioblastoma is the most common and aggressive of primary brain tumors. Despite technological advances in the surgical procedure, followed by radiotherapy and chemotherapy, the average survival of patients is 12 to 15 months. This type of tumor has high cellular heterogeneity, with complex genetic alterations that reflect high genomic instability and have persistent malignant progression, characterized by spread and invasion through the brain, resistance to traditional and new therapeutic targets and damage to normal brain tissue. An important factor for tumor progression is the acidification of the environment that is promoted by carbonic anhydrases (CAs) 9 and 12, directing to the acquisition of metastatic phenotype and chemoresistance to anticancer drugs. These processes can be reversed by specific inhibitors of CAs. E7070, a membrane waterproof sulfonamide, is a new drug for cancer treatment, with potent inhibition of these enzymes. It has in vitro and in vivo activity and prevents cell cycle progression in tumor cells. A better understanding of complex molecular and cell mechanisms, that lead to tumor progression, is an important prerequisite for the identification of new and more effective therapeutic strategies, aiming to improve survival of patients. Thus, in this project researchers propose studying the expression and the in vitro effects of inhibition of the 9/12 CAs by E7070 (alone or in combination with the currently used treatment) in chemoresistance, invasion, proliferation and apoptosis of cell lines and SSEA-1+ stem cells subjected to hypoxia. Among the studied genes, researchers will select one to analyze in in vivo model of immunocompomised mice, the effects of E7070 in the inhibition of tumor progression and, thus, survival.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
TEIXEIRA, SILVIA A.; VIAPIANO, MARIANO S.; ANDRADE, AUGUSTO F.; NANDHU, MOHAN S.; PEZUK, JULIA A.; BIDINOTTO, LUCAS T.; SUAZO, VERIDIANA K.; NEDER, LUCIANO; CARLOTTI, CARLOS G.; BECKER, ALINE P.; et al. The Carbonic Anhydrase Inhibitor E7070 Sensitizes Glioblastoma Cells to Radio- and Chemotherapy and Reduces Tumor Growth. Molecular Neurobiology, . (11/07448-1, 14/08899-5, 11/05957-6)

Please report errors in scientific publications list by writing to: